This inventor holds 1 USPTO granted patent. Top assignee: Trisalus Life Sciences, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Trevor Mccaw in Tumor Therapy
Introduction
Trevor Mccaw is an innovative inventor based in Corte Madera, CA (US). He has made significant contributions to the field of medical technology, particularly in enhancing therapy uptake within tumors. His work focuses on improving treatment methods for patients suffering from cancer.
Latest Patents
Trevor Mccaw holds a patent for a method titled "Modulation of vascular adaptation within a tumor to increase therapy uptake within the tumor." This patent describes a system that modulates vascular adaptation within a tumor to enhance the uptake of therapy. The method involves using a pressure-directed therapy system that includes an infusion lumen, an occluder, and a pressure sensor. The system is designed to advance to a target artery of an organ, reduce pressure in the target artery, and infuse therapy through the infusion lumen. The process includes sensing pressure changes and adapting the infusion cycle accordingly until the therapy dose is delivered to the patient.
Career Highlights
Trevor Mccaw is currently employed at Trisalus Life Sciences, Inc., where he continues to develop innovative solutions for cancer treatment. His work is pivotal in advancing therapeutic techniques that can significantly improve patient outcomes.
Collaborations
Trevor collaborates with notable colleagues, including Scott Davie and Michael Brick Markham. Their combined expertise contributes to the development of cutting-edge medical technologies.
Conclusion
Trevor Mccaw's contributions to the field of tumor therapy exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Trisalus Life Sciences, Inc. highlight the importance of advancements in cancer treatment methodologies.